Update on screening for prostate cancer with prostate-specific antigen.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 15094160)

Published in Crit Rev Oncol Hematol on April 01, 2004

Authors

Hans-Peter Schmid1, Walter Riesen, Ladislav Prikler

Author Affiliations

1: Department of Urology, Kantonsspital, CH-9007 St. Gallen, Switzerland. hans-peter.schmid@kssg.ch

Articles by these authors

Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care (2008) 2.22

Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation (2003) 2.00

Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis (2003) 1.55

Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health (2006) 1.46

CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood (2003) 1.46

Metabolic syndrome according to different definitions in a rapidly developing country of the African region. Cardiovasc Diabetol (2008) 1.46

Implications of emerging risk factors for therapeutic intervention. Nutr Metab Cardiovasc Dis (2005) 1.43

Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol Renal Physiol (2002) 1.21

Divergent fifteen-year trends in traditional and cardiometabolic risk factors of cardiovascular diseases in the Seychelles. Cardiovasc Diabetol (2009) 1.03

Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Clin Lab (2002) 1.01

Simvastatin improves endothelial function in patients with rheumatoid arthritis. J Am Coll Cardiol (2005) 1.01

High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV technique. Eur J Radiol (2010) 1.01

Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J Hypertens (2007) 0.97

Changes in biochemical markers after lower limb fractures. Clin Chem (2006) 0.89

Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters. Strahlenther Onkol (2009) 0.82

Integration of B-type natriuretic peptide levels with clinical data and exercise testing for predicting coronary artery disease. Am J Cardiol (2006) 0.80

B-type natriuretic peptide kinetics and cardiopulmonary exercise testing in heart failure. Int J Cardiol (2006) 0.80

Cardiopulmonary exercise testing in mild heart failure: impact of the mode of exercise on established prognostic predictors. Cardiology (2007) 0.79

Relation between high-sensitivity C-reactive protein and cardiovascular and renal markers in a middle-income country in the African region. Int J Cardiol (2011) 0.78

Problems with prostate-specific antigen screening: a critical review. Recent Results Cancer Res (2003) 0.77

Association between conventional risk factors and different ultrasound-based markers of atherosclerosis at carotid and femoral levels in a middle-aged population. Int J Cardiovasc Imaging (2012) 0.76

Preoperative fibrin monomer measurement allows risk stratification for high intraoperative blood loss in elective surgery. Thromb Haemost (2005) 0.76

Low prevalence of abdominal aortic aneurysm in the Seychelles population aged 50 to 65 years. Cardiovasc J Afr (2013) 0.75

Intermittent ureteral herniation--rare cause of flank pain. Urol Int (2006) 0.75

Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure. Wien Klin Wochenschr (2008) 0.75